Intercos SpA is engaged in the manufacturing of cosmetics. Its offerings include color cosmetics, pencils, nail polish, skincare, and personal care products. The turnover is divided across the following product families: make up products, hair and body care products, skincare products.
1972
n/a
LTM Revenue $1.2B
LTM EBITDA $158M
$1.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Intercos has a last 12-month revenue of $1.2B and a last 12-month EBITDA of $158M.
In the most recent fiscal year, Intercos achieved revenue of $1.1B and an EBITDA of $136M.
Intercos expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Intercos valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $898M | $1.1B | XXX | XXX | XXX |
Gross Profit | $156M | $192M | XXX | XXX | XXX |
Gross Margin | 17% | 18% | XXX | XXX | XXX |
EBITDA | $123M | $136M | XXX | XXX | XXX |
EBITDA Margin | 14% | 13% | XXX | XXX | XXX |
Net Profit | $29.0M | $48.1M | XXX | XXX | XXX |
Net Margin | 3% | 5% | XXX | XXX | XXX |
Net Debt | $99.5M | $74.2M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Intercos's stock price is EUR 12 (or $13).
Intercos has current market cap of EUR 1.2B (or $1.3B), and EV of EUR 1.3B (or $1.4B).
See Intercos trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$1.4B | $1.3B | XXX | XXX | XXX | XXX | $0.66 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Intercos has market cap of $1.3B and EV of $1.4B.
Intercos's trades at 1.2x LTM EV/Revenue multiple, and 8.6x LTM EBITDA.
Analysts estimate Intercos's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Intercos and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $1.4B | XXX | XXX | XXX |
EV/Revenue | 1.3x | XXX | XXX | XXX |
EV/EBITDA | 10.0x | XXX | XXX | XXX |
P/E | 22.5x | XXX | XXX | XXX |
P/E/Growth | 1.0x | XXX | XXX | XXX |
EV/FCF | 26.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpIntercos's NTM/LTM revenue growth is 7%
Intercos's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Intercos's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Intercos's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Intercos and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 18% | XXX | XXX | XXX | XXX |
EBITDA Margin | 13% | XXX | XXX | XXX | XXX |
EBITDA Growth | 10% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 20% | XXX | XXX | XXX | XXX |
Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
Opex per Employee | n/a | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
Opex to Revenue | 11% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Intercos acquired XXX companies to date.
Last acquisition by Intercos was XXXXXXXX, XXXXX XXXXX XXXXXX . Intercos acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Intercos founded? | Intercos was founded in 1972. |
Where is Intercos headquartered? | Intercos is headquartered in Italy. |
Who is the CEO of Intercos? | Intercos's CEO is Mr. Renato Semerari. |
Is Intercos publicy listed? | Yes, Intercos is a public company listed on MIL. |
What is the stock symbol of Intercos? | Intercos trades under ICOS ticker. |
When did Intercos go public? | Intercos went public in 2021. |
Who are competitors of Intercos? | Similar companies to Intercos include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
What is the current market cap of Intercos? | Intercos's current market cap is $1.3B |
What is the current revenue of Intercos? | Intercos's last 12-month revenue is $1.2B. |
What is the current EBITDA of Intercos? | Intercos's last 12-month EBITDA is $158M. |
What is the current EV/Revenue multiple of Intercos? | Current revenue multiple of Intercos is 1.2x. |
What is the current EV/EBITDA multiple of Intercos? | Current EBITDA multiple of Intercos is 8.6x. |
What is the current revenue growth of Intercos? | Intercos revenue growth between 2023 and 2024 was 18%. |
Is Intercos profitable? | Yes, Intercos is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.